Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Lingyi Biology

Lingyi Bio is a rare disease animal model functional verification platform and gene therapy developer.
2021
11 – 50
11 - 50
Shanghai, Shanghai, China

Investment Funding

Last Funding Stage

Early Stage Venture

Total Funding Amount

$30.3M

Last Funding Date

25-11-2024

Startup Stage

Series A

Lead Investors

Beijing Huafang Investment, HSG, Jolly Pharmaceutical, Matrix Partners China, Yifeng Capital

About

Lingyi Biology is a gene therapy company that uses a platform to validate the functionality of animal models of rare diseases. It is dedicated to sourcing innovation, with a focus on genetic rare diseases like metabolism, CNS, and ophthalmology. Lingyi Biology has a gene therapy and rare disease discovery, development, and industrialization team, as well as a rare disease animal model preparation and verification platform, to address the pain point of a lack of effective animal models for rare disease research and development.

Something missing or incorrect on this page? Help us enrich this information